BioTalk

On 24 September, the French National Agency for the Safety of Medicines and Health Products (ANSM) announced fines totalling €8 million...

In the rapidly evolving world of life sciences, merger control and foreign direct investment (“FDI”) regimes have emerged as key...

Like generic medicines, biological medicines that are very similar to another biological medicine (biosimilars) are included in a list...

Breach of the “anti-gift” law An investigation by the Directorate General for Fair Trading, Consumer Affairs and Fraud Control (“DGCCRF”)...

The Council of State (Conseil d’Etat) has recently annulled the government order prohibiting the sale of cannabis flowers and leaves with...